Literature DB >> 21914798

The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.

Petra Hänzelmann1, Hermann Schindelin.   

Abstract

The AAA (ATPase associated with various cellular activities) ATPase p97, also referred to as valosin-containing protein (VCP), mediates essential cellular processes, including ubiquitin-dependent protein degradation, and has been linked to several human proteinopathies. p97 interacts with multiple cofactors via its N-terminal (p97N) domain, a subset of which contain the VCP-interacting motif (VIM). We have determined the crystal structure of the p97N domain in complex with the VIM of the ubiquitin E3 ligase gp78 at 1.8 Å resolution. The α-helical VIM peptide binds into a groove located in between the two subdomains of the p97N domain. Interaction studies of several VIM proteins reveal that these cofactors display dramatically different affinities, ranging from high affinity interactions characterized by dissociation constants of ∼20 nm for gp78 and ANKZF1 to only weak binding in our assays. The contribution of individual p97 residues to VIM binding was analyzed, revealing that identical substitutions do not affect all cofactors in the same way. Taken together, the biochemical and structural studies define the framework for recognition of VIM-containing cofactors by p97. Of particular interest to the regulation of p97 by its cofactors, our structure reveals that the bound α-helical peptides of VIM-containing cofactors overlap with the binding site for cofactors containing the ubiquitin regulatory X (UBX) domain present in the UBX protein family or the ubiquitin-like domain of NPL4 as further corroborated by biochemical data. These results extend the concept that competitive binding is a crucial determinant in p97-cofactor interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914798      PMCID: PMC3207442          DOI: 10.1074/jbc.M111.274506

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  A major conformational change in p97 AAA ATPase upon ATP binding.

Authors:  I Rouiller; V M Butel; M Latterich; R A Milligan; E M Wilson-Kubalek
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

2.  A stress-responsive system for mitochondrial protein degradation.

Authors:  Jin-Mi Heo; Nurit Livnat-Levanon; Eric B Taylor; Kevin T Jones; Noah Dephoure; Julia Ring; Jianxin Xie; Jeffrey L Brodsky; Frank Madeo; Steven P Gygi; Kaveh Ashrafi; Michael H Glickman; Jared Rutter
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

3.  Detailed structural insights into the p97-Npl4-Ufd1 interface.

Authors:  Rivka L Isaacson; Valerie E Pye; Peter Simpson; Hemmo H Meyer; Xiaodong Zhang; Paul S Freemont; Steve Matthews
Journal:  J Biol Chem       Date:  2007-05-09       Impact factor: 5.157

Review 4.  Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase.

Authors:  Yihong Ye
Journal:  J Struct Biol       Date:  2006-02-20       Impact factor: 2.867

5.  Imbalances in p97 co-factor interactions in human proteinopathy.

Authors:  Vanesa Fernández-Sáiz; Alexander Buchberger
Journal:  EMBO Rep       Date:  2010-04-23       Impact factor: 8.807

6.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

7.  Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains.

Authors:  Byron DeLaBarre; Axel T Brunger
Journal:  Nat Struct Biol       Date:  2003-08-31

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover.

Authors:  Gabriela Alexandru; Johannes Graumann; Geoffrey T Smith; Natalie J Kolawa; Ruihua Fang; Raymond J Deshaies
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  38 in total

1.  A non-canonical role of the p97 complex in RIG-I antiviral signaling.

Authors:  Qian Hao; Shi Jiao; Zhubing Shi; Chuanchuan Li; Xia Meng; Zhen Zhang; Yanyan Wang; Xiaomin Song; Wenjia Wang; Rongguang Zhang; Yun Zhao; Catherine C L Wong; Zhaocai Zhou
Journal:  EMBO J       Date:  2015-10-15       Impact factor: 11.598

2.  The general definition of the p97/valosin-containing protein (VCP)-interacting motif (VIM) delineates a new family of p97 cofactors.

Authors:  Christopher Stapf; Edward Cartwright; Mark Bycroft; Kay Hofmann; Alexander Buchberger
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

3.  Cooperative subunit dynamics modulate p97 function.

Authors:  Rui Huang; Zev A Ripstein; John L Rubinstein; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-24       Impact factor: 11.205

4.  The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.

Authors:  Franziska Trusch; Anja Matena; Maja Vuk; Lisa Koerver; Helene Knævelsrud; Paul S Freemont; Hemmo Meyer; Peter Bayer
Journal:  J Biol Chem       Date:  2015-10-16       Impact factor: 5.157

5.  The ubiquitin regulatory X (UBX) domain-containing protein TUG regulates the p97 ATPase and resides at the endoplasmic reticulum-golgi intermediate compartment.

Authors:  Charisse M Orme; Jonathan S Bogan
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

6.  Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP).

Authors:  Su Jin Kim; Jinhong Cho; Eun Joo Song; Soo Jin Kim; Ho Min Kim; Kyung Eun Lee; Se Won Suh; Eunice EunKyeong Kim
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

7.  Structure and expression of a novel compact myelin protein - small VCP-interacting protein (SVIP).

Authors:  Jiawen Wu; Dungeng Peng; Markus Voehler; Charles R Sanders; Jun Li
Journal:  Biochem Biophys Res Commun       Date:  2013-09-18       Impact factor: 3.575

8.  Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming.

Authors:  Pere Llinàs-Arias; Margalida Rosselló-Tortella; Paula López-Serra; Montserrat Pérez-Salvia; Fernando Setién; Silvia Marin; Juan P Muñoz; Alexandra Junza; Jordi Capellades; María E Calleja-Cervantes; Humberto J Ferreira; Manuel Castro de Moura; Marina Srbic; Anna Martínez-Cardús; Carolina de la Torre; Alberto Villanueva; Marta Cascante; Oscar Yanes; Antonio Zorzano; Catia Moutinho; Manel Esteller
Journal:  JCI Insight       Date:  2019-03-07

Review 9.  Detection and Degradation of Stalled Nascent Chains via Ribosome-Associated Quality Control.

Authors:  Cole S Sitron; Onn Brandman
Journal:  Annu Rev Biochem       Date:  2020-06-20       Impact factor: 23.643

10.  Ubiquitin- and ATP-dependent unfoldase activity of P97/VCP•NPLOC4•UFD1L is enhanced by a mutation that causes multisystem proteinopathy.

Authors:  Emily E Blythe; Kristine C Olson; Vincent Chau; Raymond J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.